Patents by Inventor Sophie Descamps

Sophie Descamps has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors
    Patent number: 10280170
    Abstract: The present invention relates to substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives of formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as ROS1 inhibitors. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: May 7, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Laurence Anne Mevellec, Elisabeth Therese Jeanne Pasquier, Sophie Descamps, Guillaume Jean Maurice Mercey, Berthold Wroblowski, Jorge Eduardo Vialard, Lieven Meerpoel, Matthieu Ludovic Jeanty, Thierry Francois Alain Jean Jousseaume
  • SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS
    Publication number: 20170174690
    Abstract: The present invention relates to substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives of formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as ROS1 inhibitors. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
    Type: Application
    Filed: March 26, 2015
    Publication date: June 22, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Laurence Anne Mevellec, Elisabeth Therese Jeanne Pasquier, Sophie Descamps, Guillaume Jean Maurice Mercey, Berthold Wroblowski, Jorge Eduardo Vialard, Lieven Mrrtpoel, Matthieu Ludovic Jeanty, Thierry Francois Alain Jean Jousseaume
  • Indole derivatives as anticancer agents
    Patent number: 8541442
    Abstract: The present invention provides compounds of formula (I), their use for the treatment of cancer as well as pharmaceutical compositions comprising said compounds of formula (I).
    Type: Grant
    Filed: February 3, 2010
    Date of Patent: September 24, 2013
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Bruno Schoentjes, Sophie Descamps, Nathalie Claudie Isabelle Amblard
  • INDOLE DERIVATIVES AS ANTICANCER AGENTS
    Publication number: 20110294846
    Abstract: The present invention provides compounds of formula (I), their use for the treatment of cancer as well as pharmaceutical compositions comprising said compounds of formula (I).
    Type: Application
    Filed: February 3, 2010
    Publication date: December 1, 2011
    Inventors: Bruno Schoentjes, Sophie Descamps, Nathalie Claudie Isabelle Amblard
  • Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them
    Publication number: 20040072871
    Abstract: A compound of formula (I) selected from: 1
    Type: Application
    Filed: August 8, 2003
    Publication date: April 15, 2004
    Inventors: Anne-Claude Dublanchet, Delphine Compere, Philippe Cluzeau, Stephane Blais, Alexis Denis, Pierre Ducrot, Karine Courte, Sophie Descamps